Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aggrenox and Alcohol on Psychomotor Performance in Healthy Volunteers
NCT02278302Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 1999
- Primary completion
- Mar 2000
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of dipyridamole in stroke and Transient Ischemic Attack (TIA), sponsored by Boehringer Ingelheim. Primary endpoint: Change in safety relevant performance in the steady state scored by five psychomotor tests at day 11. Started Aug 1999; status: completed.
02
Drugs
dipyridamole
03
Conditions
strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT02278302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02278302.